Cvs Health (CVS) Asset Writedowns and Impairment (2022 - 2024)

Cvs Health (CVS) has 3 years of Asset Writedowns and Impairment data on file, last reported at -$840.0 million in Q4 2024.

• Quarterly Asset Writedowns and Impairment fell 326.4% year-over-year to -$840.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$430.0 million (down 362.2% YoY) and the FY2023 annual result came in at $152.0 million, down 94.0% from the prior year.
• Asset Writedowns and Impairment slipped to -$840.0 million in Q4 2024, from $607.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $2.5 billion in Q3 2022 to a low of -$840.0 million in Q4 2024.
• A 3-year average of $350.3 million and a median of $41.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 751.22% in 2023, down 1741.67% in 2023.
• Tracing CVS's Asset Writedowns and Impairment over 3 years: stood at $12.0 million in 2022, then tumbled by 1741.67% to -$197.0 million in 2023, then plunged by 326.4% to -$840.0 million in 2024.
• The last three Asset Writedowns and Impairment figures came in at -$840.0 million (Q4 2024), $607.0 million (Q3 2024), and -$197.0 million (Q4 2023), per Business Quant data.